Immunocore Limited, the Oxford based biotechnology company developing novel biological drugs to treat cancer and viral disease has announced the achievement of its first milestone in its research and licensing agreement with GlaxoSmithKline.
Oxford Today reports that Oxford is generating demand for new business leaders as never before, and alumni are prime candidates as spin-out CEOs.
Reviving a gene which is “turned down” after birth is potentially the key to treating Duchenne Muscular Dystrophy, an untreatable muscle-wasting condition which affects one in every 3,500 boys.
Colwiz has announced the launch of the first HTML5 interactive PDF reader.
Oxford University Innovation spin-out Oxford Medical Diagnostics is working on a hand-held diagnostic to identify children with diabetes before they become ill.
NaturalMotion began as a project in the Zoology Department at the University of Oxford in 2001. Working with Oxford University Innovation, CEO Torsten Reil developed a business plan and secured first-round investors for the company. NaturalMotion was acquired by Zynga in early 2014 for $527m.
Software startup Onfido has raised £500,000 in seed funding as its online real-time employee screening service is rolled out to help employers conduct vital background checks.
A spin-out from Oxford University’s Department of Engineering Science and Oxford University Innovation will target new opportunities in robotics and autonomous systems.
Oxford University Innovation, the University of Oxford’s commercialisation company, has been named “Technology Transfer Unit of the Year” at a gala dinner in London, held as part of the Global University Venturing 2014 Summit.
Brainomix, a start-up from the Isis Software Incubator, has been announced as the winner in the ICT category of the Academic Enterprise Awards 2014.
